Mavrilimumab Linked to Reduced Mortality And Mechanical Ventilation In Patients Hospitalized With Severe COVID-19, Study Finds

Healio (6/7, Volansky) reports on research finding that “a single dose of the granulocyte/macrophage-colony stimulating factor antibody mavrilimumab was linked to reduced mortality and mechanical ventilation in patients hospitalized for severe COVID-19.”...